Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Zammit

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 7, 2022
Role of tau deposition in early cognitive decline in Down syndromeSigan L Hartley, Benjamin L Handen, Dana Tudorascu, et al.
Journal of Neurodevelopmental Disorders|April 21, 2021
White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics studyAustin Bazydlo, Matthew Zammit, Minjie Wu, et al.
Neurobiology of Aging|August 24, 2021
Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndromeVictoria Fleming, Brianna Piro-Gambetti, Austin Patrick, et al.
EJNMMI Research|August 8, 2020
[<sup>18</sup>F]FEPPA PET imaging for monitoring CD68-positive microglia/macrophage neuroinflammation in nonhuman primatesMatthew Zammit, Yunlong Tao, Miles E Olsen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
AT(N) biomarker profiles and Alzheimer's disease symptomology in Down syndromeSigan L Hartley, Benjamin Handen, Dana Tudorascu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2025
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's diseaseVictoria L Fleming, Jamie Peven, Brian C Helsel, et al.
Nature Medicine|March 2, 2021
Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeysYunlong Tao, Scott C Vermilyea, Matthew Zammit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndromeAnna H Boerwinkle, Julie K Wisch, Benjamin L Handen, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populationsAndrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 7, 2022
Role of tau deposition in early cognitive decline in Down syndromeSigan L Hartley, Benjamin L Handen, Dana Tudorascu, et al.
Journal of Neurodevelopmental Disorders|April 21, 2021
White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics studyAustin Bazydlo, Matthew Zammit, Minjie Wu, et al.
Neurobiology of Aging|August 24, 2021
Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndromeVictoria Fleming, Brianna Piro-Gambetti, Austin Patrick, et al.
EJNMMI Research|August 8, 2020
[<sup>18</sup>F]FEPPA PET imaging for monitoring CD68-positive microglia/macrophage neuroinflammation in nonhuman primatesMatthew Zammit, Yunlong Tao, Miles E Olsen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
AT(N) biomarker profiles and Alzheimer's disease symptomology in Down syndromeSigan L Hartley, Benjamin Handen, Dana Tudorascu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2025
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's diseaseVictoria L Fleming, Jamie Peven, Brian C Helsel, et al.
Nature Medicine|March 2, 2021
Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeysYunlong Tao, Scott C Vermilyea, Matthew Zammit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndromeAnna H Boerwinkle, Julie K Wisch, Benjamin L Handen, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populationsAndrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Pageof 4